Newsroom
Sorted by: Latest
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share FIRST TRUST BLOOMBERG GLOBAL SEMICONDUCTOR SUPPLY CHAIN UCITS ETF 20.03.2026 CHPS.LN IE000KXTLDE2 700,002.00 USD 24,326,038.33 34.751 ...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Indxx Global Aerospace & Defence UCITS ETF 20.03.2026 MISL.LN IE000NVDQXE1 3,650,002.00 USD 125,360,221.03 34.345 ...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest Nasdaq-100 Moderate Buffer UCITS ETF - September 20.03.2026 QSEP.LN IE000FQ808R5 400,002.00 USD 8,935,957.03 22.340 ...
-
Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial
NEW YORK & LYON, France--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) and Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) today announced topline results from the Phase 3 VALOR “Vaccine Against Lyme for Outdoor Recreationists” clinical trial (NCT05477524) of its investigational 6-valent OspA-based Lyme disease vaccine candidate PF-07307405 (LB6V, formerly known as VLA15) demonstrating: In the pre-specified analyses: Efficacy of 73.2% from 28 days post-dose 4 (season 2) in reducing the rate of confir...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Moderate Buffer UCITS ETF - May 20.03.2026 GMAY.LN IE000P0FL8E3 900,002.00 USD 34,191,036.89 37.990 ...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Momentum UCITS ETF 20.03.2026 FTMO.LN IE000CY30YV9 3,050,002.00 USD 78,286,754.00 25.668 ...
-
NATIXIS UK Regulatory Announcement: Form 8.3
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: NATIXIS SA (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name o...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest US Equity Max Buffer UCITS ETF - March 20.03.2026 MMAR.LN IE0002PPCMH6 50,002.00 USD 1,301,334.98 26.026 ...
-
Samsung Biologics Labor Union Warns of "Structural Supply Chain Risk" Amid Labor Dispute, Highlighting Systemic Governance Failures
INCHEON, South Korea--(BUSINESS WIRE)--Samsung Biologics union (75% of workforce) warns of strike and global supply chain risks stemming from severe ESG and governance failures....
-
Gewerkschaft von Samsung Biologics warnt vor „strukturellem Lieferkettenrisiko“ durch Arbeitskonflikte und verweist auf systemisches Versagen der Unternehmensführung
INCHEON, Südkorea--(BUSINESS WIRE)--Der Arbeitskonflikt bei Samsung Biologics, dem weltweit führenden Auftragsentwicklungs- und Produktionsunternehmen (CDMO), hat einen kritischen Punkt erreicht. Laut der Gewerkschaft von Samsung Biologics (Gewerkschaftsvorsitzender: Jaesung Park), die etwa 75 % der Belegschaft des Unternehmens vertritt, handelt es sich bei dem anhaltenden Konflikt nicht allein um einen Tarifstreit, sondern um ein erhebliches Geschäftsrisiko, das auf strukturelle Mängel einer u...